First Allied Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-222,395
Closed -$7.4M 108
2015
Q1
$7.4M Sell
222,395
-11,607
-5% -$369K 1.04% 30
2014
Q4
$6.95M Sell
234,002
-6,539
-3% -$187K 0.97% 42
2014
Q3
$6.86M Buy
240,541
+18,668
+8% +$524K 0.92% 44
2014
Q2
$6.34M Buy
221,873
+9,275
+4% +$264K 0.93% 51
2014
Q1
$6.55M Buy
212,598
+3,451
+2% +$103K 0.95% 39
2013
Q4
$6.14M Buy
209,147
+8,470
+4% +$247K 0.88% 51
2013
Q3
$5.5M Buy
200,677
+14,732
+8% +$401K 0.83% 54
2013
Q2
$5M Buy
+185,945
New +$5.14M 0.72% 50

Other funds holding PFE

First Allied Asset Management's PFE Position: Q2 2015 in Review

First Allied Asset Management sold out of Pfizer (PFE) in Q2 2015, closing a stake of 222,395 shares — an estimated $7.4M sold.

First Allied Asset Management first reported a position in PFE in Q2 2013 and held it in 8 quarters. The position peaked at $7.4M in Q1 2015. 1,886 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

  • First Allied Asset Management reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
  • First Allied Asset Management sold 222,395 Pfizer shares in Q2 2015, an estimated $7.4M.
  • First Allied Asset Management first reported a position in Pfizer in Q2 2013 and held it in 8 quarters.
  • First Allied Asset Management's Pfizer position peaked at $7.4M in Q1 2015.
  • 1,886 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on First Allied Asset Management's 13F filing for Q2 2015.